Please Wait
Applying Filters...
menu
    • menu
    Mikart-PSE
    News
    Mikart Supports Cannabinoid & Psilocybin Drug Development

    18 Apr 2025

    // PRESS RELEASE

    Liquid Suspension Trends in the CDMO Space

    21 Feb 2025

    // PRESS RELEASE

    Mikart Celebrates 50 year of Excellence in Pharma Manufacturing

    16 Jan 2025

    // PRESS RELEASE

    Data Compilation
    #PharmaFlow

    Mikart

    Contact Supplier

    Website

    Contract Pharma

    Attending

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.pharmacompass.com/video-supplier-spotlight/mikart/corporate-video
    Left Arrow
    Right Arrow

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Related CompaniesRelated Companies

    About

    Mikart is a privately owned contract development and manufacturing organization (CDMO) that has consistently delivered top-notch products for over 50 years. Mikart’s capabilities span across various areas, such as product development, regulatory services, clinical trial supplies, analytical services, solid or liquid oral dose manufacturing and packaging. Mikart's specialty lies in non-sterile oral liquid and oral solid dosage forms, particularly in controlled substances, geriatrics and pediatrics, from formulation to full-scale commercialization. Mikart adheres to all current FDA and cGMP standards to ensure top-quality output.